weight regain after stopping glp-1 agonists Trajectory of the body drug discontinuation in the treatment of anti-obesity medications | BMC Medicine GLP-1 weight loss effects after
Description
This update elevates obesity within the global noncommunicable disease agenda and sets a clear mandate for action
doi: 10.1017/S0007114515000550
The impact of this is that the formularies cost sharing has shifted and many Part D providers have changed plans and/or left unsustainable service areas altogether
More serious but less common adverse effects require clinical vigilance
The recommended daily allowances (RDAs) for total fiber intake for men and women aged 1950 are 38 gram/day and 25 gram/day, respectively
